Families of kids with PDCD are urging the FDA to approve DCA, a treatment that could extend their children's lives despite ...

Dr. Kurt Miceli, medical director for the advocacy group Do No Harm, presented at the CDC’s twice-yearly conference to update U.S. medical codes to include side effects for detransitioners, or those ...

Breast cancer is already costing the UK economy between £3.2bn and £3.5bn - but could rise to £4.2bn in the next 25 years ...

Duke-NUS study finds that better data, smarter treatment plans and more realistic targets are needed to tackle anaemia, which ...

New research from Yale SOM’s Mushfiq Mobarak shows that the violence and looting in rice-growing areas is tied to rice prices ...

The development of artificial intelligence in medicine and pharmacy has been discussed for years, but there is still no ...

J. Tyler Davidson of the Department of Forensic Science at Sam Houston State University (Huntsville, Texas) used liquid ...

Perioperative immunotherapy for the treatment of non-small cell lung cancer is starting to exhibit survival benefits among ...

What doesn't make sense is this sudden urgency among an unknown "business community" cabal. This secret society is pulling ...

Annual revisions are normal, but this one is pretty significant: it’s the largest since the 2008 recession. It also comes at ...

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

Backed by top industrialists before Ashoka University was even an idea, IIHS was built to tackle India’s urban mess. It ...